Image6_Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma.JPEG by Bilge Sari (16989051)

“…To explore possible mechanisms, we investigated co-expressed genes, identifying eight hub genes, namely, GJB3, ITGB6, SERPINB5, GPRC5A, PLEK2, TMPRSS4, P2RY2, and TRIM29, which are co-expressed with all three of LAMA3, LAMB3, and LAMC2. …”

Image2_Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma.JPEG by Bilge Sari (16989051)

“…To explore possible mechanisms, we investigated co-expressed genes, identifying eight hub genes, namely, GJB3, ITGB6, SERPINB5, GPRC5A, PLEK2, TMPRSS4, P2RY2, and TRIM29, which are co-expressed with all three of LAMA3, LAMB3, and LAMC2. …”

Image4_Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma.JPEG by Bilge Sari (16989051)

“…To explore possible mechanisms, we investigated co-expressed genes, identifying eight hub genes, namely, GJB3, ITGB6, SERPINB5, GPRC5A, PLEK2, TMPRSS4, P2RY2, and TRIM29, which are co-expressed with all three of LAMA3, LAMB3, and LAMC2. …”

Image7_Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma.JPEG by Bilge Sari (16989051)

“…To explore possible mechanisms, we investigated co-expressed genes, identifying eight hub genes, namely, GJB3, ITGB6, SERPINB5, GPRC5A, PLEK2, TMPRSS4, P2RY2, and TRIM29, which are co-expressed with all three of LAMA3, LAMB3, and LAMC2. …”

Image3_Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma.JPEG by Bilge Sari (16989051)

“…To explore possible mechanisms, we investigated co-expressed genes, identifying eight hub genes, namely, GJB3, ITGB6, SERPINB5, GPRC5A, PLEK2, TMPRSS4, P2RY2, and TRIM29, which are co-expressed with all three of LAMA3, LAMB3, and LAMC2. …”

Image9_Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma.JPEG by Bilge Sari (16989051)

“…To explore possible mechanisms, we investigated co-expressed genes, identifying eight hub genes, namely, GJB3, ITGB6, SERPINB5, GPRC5A, PLEK2, TMPRSS4, P2RY2, and TRIM29, which are co-expressed with all three of LAMA3, LAMB3, and LAMC2. …”

Sanger sequencing validation of chimera virus. by Hui Wang (30400)

“…(B) SNP profile of the 5’ recombination junction using the Sanger sequences, showing a decrease of polymorphism after the recombination junction. …”

Table_2_Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms.docx by Yasmin Silva Rizk (10195547)

“…Using BALB/c mice infected with L. amazonensis we verified the effect of an intralesional treatment with amentoflavone (0.05 mg/kg/dose, in a total of 5 doses every 4 days). …”

Table_1_Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms.docx by Yasmin Silva Rizk (10195547)

“…Using BALB/c mice infected with L. amazonensis we verified the effect of an intralesional treatment with amentoflavone (0.05 mg/kg/dose, in a total of 5 doses every 4 days). …”

Table_1_Characterizing the Microbial Consortium L1 Capable of Efficiently Degrading Chlorimuron-Ethyl via Metagenome Combining 16S rDNA Sequencing.DOCX by Xiang Li (114679)

“…The consortium could degrade 98.04% of 100 mg L⁻¹ CE within 6 days. We characterized it from the samples at four time points during the degradation process and a sample without degradation activity via metagenome and 16S rDNA sequencing. …”

Table_2_Characterizing the Microbial Consortium L1 Capable of Efficiently Degrading Chlorimuron-Ethyl via Metagenome Combining 16S rDNA Sequencing.DOCX by Xiang Li (114679)

“…The consortium could degrade 98.04% of 100 mg L⁻¹ CE within 6 days. We characterized it from the samples at four time points during the degradation process and a sample without degradation activity via metagenome and 16S rDNA sequencing. …”

Image_1_Characterizing the Microbial Consortium L1 Capable of Efficiently Degrading Chlorimuron-Ethyl via Metagenome Combining 16S rDNA Sequencing.TIF by Xiang Li (114679)

“…The consortium could degrade 98.04% of 100 mg L⁻¹ CE within 6 days. We characterized it from the samples at four time points during the degradation process and a sample without degradation activity via metagenome and 16S rDNA sequencing. …”

Table_4_Characterizing the Microbial Consortium L1 Capable of Efficiently Degrading Chlorimuron-Ethyl via Metagenome Combining 16S rDNA Sequencing.XLSX by Xiang Li (114679)

“…The consortium could degrade 98.04% of 100 mg L⁻¹ CE within 6 days. We characterized it from the samples at four time points during the degradation process and a sample without degradation activity via metagenome and 16S rDNA sequencing. …”

Table_3_Characterizing the Microbial Consortium L1 Capable of Efficiently Degrading Chlorimuron-Ethyl via Metagenome Combining 16S rDNA Sequencing.XLSX by Xiang Li (114679)

“…The consortium could degrade 98.04% of 100 mg L⁻¹ CE within 6 days. We characterized it from the samples at four time points during the degradation process and a sample without degradation activity via metagenome and 16S rDNA sequencing. …”

Crested capuchin suitability change by Neander Marcel Heming (12113946)

“…Plots compare increase/decrease of suitability between the reference scenario and each of the projected scenarios for the years 2050 and 2070 and RCPs 4.5 and 8.5. …”

Data_Sheet_1_Inflammation and Mechanical Stress Stimulate Osteogenic Differentiation of Human Aortic Valve Interstitial Cells.docx by Maria Bogdanova (5989997)

“…</p><p>Results: Treatment with lipopolysaccharide increased expression of osteogenic gene bone morphogenetic protein 2 (BMP2) (5-fold increase from control; p = 0.02) and decreased expression of mRNA of myofibroblastic markers: α-smooth muscle actin (ACTA2) (50% reduction from control; p = 0.0006) and calponin (CNN1) (80% reduction from control; p = 0.0001) when cells from calcified valves were cultured on collagen, but not on elastin. …”

Bacterial phagocytosis screen. by Fabrizio Lombardo (227219)

“…<p>(A) Venn diagram showing the results of the z-score and ANOVA analyses of data obtained with the microplate reader phagocytosis assay. …”

Changes in ambiguity and risk attitudes following the intervention. by Ruonan Jia (4731072)

“…<p>Violin and box plots of: (A) Ambiguity attitude, calculated as the difference between the choice proportion of ambiguous lotteries and the modeled choice proportion of 50% risky lotteries, before and after intervention for each group: Active Calculation, Non-active Calculation, and control. …”

H₂S inhibits basolateral K⁺ channels. by Alexandra Erb (588278)

“…<b>B</b>) The application of NaHS (1 mM) after nystatin permeabilisation resulted in a current decrease (from 47.2±5.12 µA/cm² to 36.4±2.93 µA/cm²; n = 5, N = 5, p≤0.05). …”

Differentially expressed proteins involved in coagulation and fibrinolysis. by Bin Liu (5899)

“…<p>(<b>A</b>) Annexin A5 inhibits coagulation. The coagulation activation process in this panel has been previously described in Harrison’s Principles of Internal Medicine (ref. 27 ). …”